What is Stoke Therapeutics, Inc.'s other current assets?

Stoke Therapeutics, Inc. (STOK) reported other current assets of $6.88M in Q1 2026.

How has Stoke Therapeutics, Inc.'s other current assets changed year-over-year?

Stoke Therapeutics, Inc.'s other current assets increased by 36.6% year-over-year, from $5.04M to $6.88M.

What is the long-term trend for Stoke Therapeutics, Inc.'s other current assets?

Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s other current assets has grown at a 18.6% compound annual growth rate (CAGR), from $2.22M to $4.39M.

Stoke Therapeutics, Inc. STOK Other current assets

Other current assets at other companies

Ionis PharmaceuticalsIONS

——

Jazz PharmaceuticalsJAZZ

——

Harmony Biosciences Holdings, Inc.HRMY

——

Sarepta Therapeutics, Inc.SRPT

——

Relay Therapeutics, Inc.RLAY

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$6.2M-96.1%

Operating income-$53.4M-148%

Net income-$50.0M-144%

EPS (diluted)-$0.79-142%

Balance sheet

See full

Cash & equivalents$155.7M-43.4%

Total debt$3.4M-42.5%

Total equity$394.9M+12.8%

Total assets$443.3M+8.9%

Cash flow

See full

Operating cash flow-$60.6M-146%

CapEx$353.0K+132%

Free cash flow-$60.9M-146%

Valuation

See full

Market cap$1.94B+436%

Enterprise value$1.79B+1,855%

P/S60.4×+58.5×

Profitability

See full

Operating margin-577.5%-597pp

Net margin-529.2%-556pp

FCF margin36.2%+18.4pp

Returns & leverage

See full

Return on equity-45.6%-66.1pp

Debt / equity0×0.0×

Current ratio9×+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s other current assets?: Stoke Therapeutics, Inc. (STOK) reported other current assets of $6.88M in Q1 2026.
How has Stoke Therapeutics, Inc.'s other current assets changed year-over-year?: Stoke Therapeutics, Inc.'s other current assets increased by 36.6% year-over-year, from $5.04M to $6.88M.
What is the long-term trend for Stoke Therapeutics, Inc.'s other current assets?: Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s other current assets has grown at a 18.6% compound annual growth rate (CAGR), from $2.22M to $4.39M.